Sumitomo Mitsui Trust Holdings, Inc. Astrazeneca PLC Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $145 Billion
- Q4 2024
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 85,127 shares of AZN stock, worth $6.04 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
85,127
Previous 84,511
0.73%
Holding current value
$6.04 Million
Previous $6.59 Million
15.31%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding AZN
# of Institutions
1,336Shares Held
477MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.46 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.98 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.64 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.61 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.36 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $220B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...